Victrex plc (LON:VCT)’s share price passed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $2,110.65 and traded as high as $2,348.00. Victrex shares last traded at $2,340.00, with a volume of 227,466 shares traded.
Several research firms have recently issued reports on VCT. Barclays dropped their price objective on shares of Victrex from GBX 2,020 ($26.39) to GBX 1,940 ($25.35) and set an “equal weight” rating for the company in a research report on Wednesday, November 27th. UBS Group reissued a “neutral” rating on shares of Victrex in a research report on Monday, November 25th. Credit Suisse Group reissued an “outperform” rating on shares of Victrex in a research report on Tuesday, November 12th. Peel Hunt reissued a “hold” rating on shares of Victrex in a research report on Monday, September 16th. Finally, Liberum Capital reaffirmed a “buy” rating on shares of Victrex in a report on Monday, October 7th. Eight equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company. The stock has an average rating of “Hold” and a consensus price target of GBX 2,261.50 ($29.55).
The stock’s fifty day moving average is GBX 2,287.72 and its two-hundred day moving average is GBX 2,110.65. The firm has a market capitalization of $2.03 billion and a price-to-earnings ratio of 20.35.
Victrex plc, through its subsidiaries, manufactures and sells polymers worldwide. The company offers VICTREX PEEK polymer materials; and biomaterial solutions for use in spine, ortho, dental, trauma, knee, cardiovascular, and orthopedic applications. It also offers specialist solutions for medical device manufacturers.
Recommended Story: How liquidity affects the bid-ask spread
Receive News & Ratings for Victrex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victrex and related companies with MarketBeat.com's FREE daily email newsletter.